A detailed history of Kings Path Partners LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Kings Path Partners LLC holds 19,418 shares of ANIP stock, worth $1.05 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
19,418
Previous 16,332 18.9%
Holding current value
$1.05 Million
Previous $1.04 Billion 11.39%
% of portfolio
0.49%
Previous 0.49%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$54.33 - $65.72 $167,662 - $202,811
3,086 Added 18.9%
19,418 $1.16 Billion
Q2 2024

Jul 30, 2024

BUY
$58.53 - $68.82 $955,911 - $1.12 Million
16,332 New
16,332 $1.04 Billion

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $944M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Kings Path Partners LLC Portfolio

Follow Kings Path Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kings Path Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kings Path Partners LLC with notifications on news.